Contract facts
UnrestrictedNo full NAICS 541714 intel page yet. Browse NAICS intelligence
A MODEL-BASED SYSTEMS ENGINEERING APPROACH TO END-TO-END PHARMACEUTICAL MANUFACTURING OF LIQUID is a federal Unrestricted award for Fda Office Of Acq Grant Svcs held by National Institute for Pharmaceutical Technology and Education, Inc. Estimated value $5M ($4.3M obligated). Current period of performance ends Sep 29, 2026 (potential Sep 29, 2027). Last award drew 1 bidder. Place of performance: MINNEAPOLIS MN. Related solicitation FDABAA-22-00123.
A MODEL-BASED SYSTEMS ENGINEERING APPROACH TO END-TO-END PHARMACEUTICAL MANUFACTURING OF LIQUID
Recompete timing
PublicCurrent PoP ends Sep 29, 2026 (2 days remaining). Agencies typically plan 12–18 months ahead — at 0.1 months out, that window is already open. The buying decision is likely already in motion.
Want the durability read on 75F40122C00122? One Pursuit Analysis, $500, inside 48 business hours.
- 48 business hours
- $500
- Credits toward the Pack
Incumbent footprint
Public recordNational Institute for Pharmaceutical Technology and Education, Inc — $1.5M obligated across 3 awards (firm-wide, all agencies).
Query this award live in SCOUT via MCP — personalized scoring, watchlists, and capture workflow across the corpus. Learn about SCOUT MCP →
Frequently asked questions
What is contract 75F40122C00122?
75F40122C00122 (Model-based systems engineering) is a Fda Office Of Acq Grant Svcs award with a potential value of $5M, currently held by National Institute for Pharmaceutical Technology and Education, Inc. Figures are USASpending-sourced public-record facts plus SCOUT recompete analysis.
Which office awarded 75F40122C00122?
Fda Office Of Acq Grant Svcs awarded 75F40122C00122 to National Institute for Pharmaceutical Technology and Education, Inc (potential $5M).
Who is the incumbent on 75F40122C00122?
National Institute for Pharmaceutical Technology and Education, Inc is the incumbent with $1.5M across 3 related awards in SCOUT’s public footprint. The current period of performance ends Sep 29, 2026.
When does National Institute for Pharmaceutical Technology and Education, Inc’s 75F40122C00122 come up for recompete?
SCOUT tracks a period-of-performance end of Sep 29, 2026. Actual solicitation timing can shift with extensions, bridges, or consolidations.
Want the durability read on 75F40122C00122? One Pursuit Analysis, $500, inside 48 business hours.
One Pursuit Analysis is $500 and credits toward the Sprint Pack. Delivery is 48 business hours. Start with the free Exposure Check if you want the list first.
No card · under a minute · then the Sprint menu
Buy one Pursuit Analysis — $500Credits toward the Sprint Pack
Compare plansData: Showing contracts ≥ $100K from federal procurement records (FPDS-NG, SAM.gov, and related repositories), normalized by PrimeRFP SCOUT. Each row keyed by Award ID (PIID); task orders appear as independent rows.